@BIOASTER receives $885K grant from the Bill & Melinda Gates Foundation @gatesfoundation to develop #Onchocerciasis advanced rapid #diagnostic with @mologic Ltd. BIOASTER, today announced it has received a grant in...
Have a look to our brand new video online on EXPERTISES @BIOASTER’s series about SMART OMICS: Video SMART OMICS The BIOASTER omics Hub team presents SMART OMICS concept. Omics technologies...
BioFilm Pharma and BIOASTER announced the signature of a research contract to address the challenge of antibiotic resistance. This collaboration will lead to the deciphering of the mode of action...
#OmicsTechnologies are today in the heart of early research in #microbiology and #InfectiousDiseases. To leverage these #technologies in applied research, we need to develop new solutions corresponding to industrial processes...
Meet us at the first DxPx – Diagnostics Partnering conference in Dusseldorf on November 18th Sara Fröjdö, Partnership Manager at BIOASTER, will be present at the 1st DxPx Diagnostics Partnering...
Microfluidics BIOASTER will be attending the 7th Annual Single Cell Analysis Congress 07 – 08 November 2019, London, UK Dr. Yacine Bounab (Biological systems & Advanced Optics Engineering Unit) will present...
Dynamiser la recherche sur le microbiote. Deux lauréats du Programme des Investissements d’Avenir (PIA), #Metagenopolis @INRA (démonstrateur pré-industriel, Lauréat 2012) et @BIOASTER (L’Institut de Recherche Technologique en microbiologie, Lauréat 2012),...
BIOASTER announces the kick off a new IMI project “GNA NOW” (Gram-Negative Antibacterials NOW), led by Evotec SE, managed by Lygature and funded by the Innovative Medicines Initiative (IMI),...
Debiopharm & BIOASTER join forces to expand research to combat infectious diseases. Debiopharm and BIOASTER announced having officialized a broad research agreement for the development of diagnostic and management innovation...
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptRejectRead More
